PF-03654764
- Generic Name
- PF-03654764
- Drug Type
- Small Molecule
- Chemical Formula
- C20H28F2N2O
- CAS Number
- 935840-35-0
- Unique Ingredient Identifier
- FPI2G03BJ1
- Background
PF-03654764 has been used in trials studying the basic science and treatment of Allergic Rhinitis.
A Study To Investigate The Safety And Toleration Of Multiple Oral Doses Of PF-03654764 In Combination With Fexofenadine In Healthy Subjects
Phase 1
Terminated
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2011-02-17
- Last Posted Date
- 2019-02-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 36
- Registration Number
- NCT01298505
- Locations
- 🇸🇬
Pfizer Clinical Research Unit, Singapore, Singapore
The Effect Of PF-03654764 +/- Allegra On Symptoms Of Allergic Rhinitis
Phase 2
Completed
- Conditions
- Allergic Rhinitis
- Interventions
- First Posted Date
- 2009-12-16
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 64
- Registration Number
- NCT01033396
- Locations
- 🇨🇦
Pfizer Investigational Site, Kingston, Ontario, Canada
A Study In Healthy People To Investigate The Safety, Toleration And Time Course Of Blood Concentrations Of Multiple Doses Of PF-03654764, Given By Mouth
- First Posted Date
- 2009-10-05
- Last Posted Date
- 2009-12-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 36
- Registration Number
- NCT00989391
- Locations
- 🇸🇬
Pfizer Investigational Site, Singapore, Singapore
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath